Viability, morphology, and proteome of Mycobacterium smegmatis MSMEG_0319 knockout strain

Proteomics
Shanshan ShaYufang Ma

Abstract

Mycobacterium tuberculosis Rv0228, a membrane protein, is predicted as a drug target through computational methods. MSMEG_0319 (MS0319) in Mycobacterium smegmatis mc(2) 155 is the ortholog of Rv0228. To study the effect of MS0319 protein on M. smegmatis, an MS0319 gene knockout strain (ΔMS0319) was generated via a homologous recombination technique in this study. The results showed that the lack of MS0319 protein in mc(2) 155 cells led to the loss of viability at nonpermissive temperature. Scanning electron microscopy and transmission electron microscopy observations showed drastic changes in cellular shape especially cell wall disruption in ΔMS0319 cells. Proteomic analysis of ΔMS0319 cells through LC-MS/MS revealed that 462 proteins had changes in their expressions by lacking MS0319 protein. The M. tuberculosis orthologs of these 462 proteins were found through BLASTp search and functional clustering and metabolic pathway enrichment were performed on the orthologs. The results revealed that most of them were enzymes involved in metabolism of carbohydrates and amino acids, indicating that Rv0228 played an important role in cellular metabolism. All these results suggested Rv0228 as a potential target for development of antitube...Continue Reading

References

Oct 9, 2002·Microbiology·Jean-Christophe CamusStewart T Cole
Jan 10, 2003·The New England Journal of Medicine·Carole MitnickPaul Farmer
Mar 27, 2003·Molecular Microbiology·Christopher M SassettiEric J Rubin
Dec 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Damien PortevinChristophe Guilhot
Nov 2, 2005·PLoS Computational Biology·Karthik RamanNagasuma Chandra
Feb 14, 2006·Biochemical and Biophysical Research Communications·Wei LiYufang Ma
Oct 18, 2006·Antimicrobial Agents and Chemotherapy·Silvia BuroniEdda De Rossi
Nov 1, 2007·Infectious Disorders Drug Targets·Clifton E BarryMichael R McNeil
Mar 4, 2008·Microbiology·Michael Niederweis
Apr 25, 2008·The Journal of Biological Chemistry·Axel SiroyMichael Niederweis
Oct 26, 2011·Antimicrobial Agents and Chemotherapy·Valentina La RosaEdda De Rossi
Dec 23, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zarir F UdwadiaCamilla Rodrigues
Feb 22, 2012·Nature Chemical Biology·Anna E GrzegorzewiczMary Jackson
Mar 27, 2012·The Journal of Infectious Diseases·Christian LienhardtJan Gheuens
May 1, 2013·Nature Reviews. Drug Discovery·Alimuddin ZumlaStewart T Cole
Jun 19, 2013·International Journal of Applied & Basic Medical Research·Rajiv Mahajan
Jul 3, 2013·The European Respiratory Journal·Giovanni SotgiuGiovanni Battista Migliori
Sep 17, 2013·Journal of Proteomics·Bhavnesh KumarDeepa Bisht
Dec 20, 2013·Nature Communications·Shichun LunWilliam R Bishai
Aug 7, 2014·The Journal of Antibiotics·Giovanna Riccardi, Maria Rosalia Pasca

❮ Previous
Next ❯

Citations

May 3, 2018·Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology·Shanshan ShaYufang Ma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.